487 related articles for article (PubMed ID: 11527248)
21. Effect of IVL745, a VLA-4 antagonist, on allergen-induced bronchoconstriction in patients with asthma.
Norris V; Choong L; Tran D; Corden Z; Boyce M; Arshad H; Holgate S; O'Connor B; Millet S; Miller B; Rohatagi S; Kirkesseli S
J Allergy Clin Immunol; 2005 Oct; 116(4):761-7. PubMed ID: 16210048
[TBL] [Abstract][Full Text] [Related]
22. Benefits of induced sputum for the evaluation of therapeutic efficacy in patients with bronchial asthma.
Ohnishi H; Maeda H; Nishimura Y; Yokoyama M
Kobe J Med Sci; 1998 Aug; 44(4):149-61. PubMed ID: 10352494
[TBL] [Abstract][Full Text] [Related]
23. Markers of allergic inflammation in peripheral blood of children with asthma after treatment with inhaled triamcinolone acetonide.
Stelmach I; Jerzynska J; Kuna P
Ann Allergy Asthma Immunol; 2001 Oct; 87(4):319-26. PubMed ID: 11686425
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of blood eosinophilia and the eosinophil cationic protein (ECP) in the serum of asthmatic children with varying degree of severity.
Vilá-Indurain B; Muñoz-López F; Martín-Mateos M
Allergol Immunopathol (Madr); 1999; 27(6):304-8. PubMed ID: 10611555
[TBL] [Abstract][Full Text] [Related]
25. A randomized controlled trial on the effect of montelukast on sputum eosinophil cationic protein in children with corticosteroid-dependent asthma.
Strauch E; Moske O; Thoma S; Storm Van's Gravesande K; Ihorst G; Brandis M; Kuehr J
Pediatr Res; 2003 Aug; 54(2):198-203. PubMed ID: 12736396
[TBL] [Abstract][Full Text] [Related]
26. Total eosinophil cationic protein levels in induced sputum as a marker of changes in eosinophilic inflammation in a patient with allergic asthma.
Barck C; Lundahl J; Halldén G; Bylin G
Ann Allergy Asthma Immunol; 2005 Jul; 95(1):86-92. PubMed ID: 16095147
[TBL] [Abstract][Full Text] [Related]
27. The effect of montelukast (MK-0476), a cysteinyl leukotriene receptor antagonist, on allergen-induced airway responses and sputum cell counts in asthma.
Diamant Z; Grootendorst DC; Veselic-Charvat M; Timmers MC; De Smet M; Leff JA; Seidenberg BC; Zwinderman AH; Peszek I; Sterk PJ
Clin Exp Allergy; 1999 Jan; 29(1):42-51. PubMed ID: 10051701
[TBL] [Abstract][Full Text] [Related]
28. Effect of inhaled interleukin-5 on airway hyperreactivity and eosinophilia in asthmatics.
Shi HZ; Xiao CQ; Zhong D; Qin SM; Liu Y; Liang GR; Xu H; Chen YQ; Long XM; Xie ZF
Am J Respir Crit Care Med; 1998 Jan; 157(1):204-9. PubMed ID: 9445301
[TBL] [Abstract][Full Text] [Related]
29. Challenge of isolated sputum cells supports in vivo origin of intolerance reaction to aspirin/non-steroidal anti-inflammatory drugs in asthma.
Higashi A; Kumlin M; Higashi N; Daham K; Gaber F; Lindeberg A; James A; Skedinger M; Delin I; Gyllfors P; Dahlén SE; Dahlén B
Int Arch Allergy Immunol; 2012; 158(3):299-306. PubMed ID: 22398682
[TBL] [Abstract][Full Text] [Related]
30. Cysteinyl leukotrienes overproduction and mast cell activation in aspirin-provoked bronchospasm in asthma.
Sladek K; Szczeklik A
Eur Respir J; 1993 Mar; 6(3):391-9. PubMed ID: 8386106
[TBL] [Abstract][Full Text] [Related]
31. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia.
Nair P; Pizzichini MM; Kjarsgaard M; Inman MD; Efthimiadis A; Pizzichini E; Hargreave FE; O'Byrne PM
N Engl J Med; 2009 Mar; 360(10):985-93. PubMed ID: 19264687
[TBL] [Abstract][Full Text] [Related]
32. Effects of oral prednisone on sputum eosinophils and cytokines in patients with severe refractory asthma.
Dente FL; Bacci E; Bartoli ML; Cianchetti S; Costa F; Di Franco A; Malagrinò L; Vagaggini B; Paggiaro P
Ann Allergy Asthma Immunol; 2010 Jun; 104(6):464-70. PubMed ID: 20568377
[TBL] [Abstract][Full Text] [Related]
33. Liposome-entrapped D. pteronyssinus vaccination in mild asthma patients: effect of 1-year double-blind, placebo-controlled trial on inflammation, bronchial hyperresponsiveness and immediate and late bronchial responses to the allergen.
Alvarez MJ; Echechipía S; García B; Tabar AI; Martín S; Rico P; Olaguibel JM
Clin Exp Allergy; 2002 Nov; 32(11):1574-82. PubMed ID: 12569977
[TBL] [Abstract][Full Text] [Related]
34. Airway eosinophilic inflammation and bronchial hyperresponsiveness after allergen inhalation challenge in asthma.
Oddera S; Silvestri M; Penna R; Galeazzi G; Crimi E; Rossi GA
Lung; 1998; 176(4):237-47. PubMed ID: 9617740
[TBL] [Abstract][Full Text] [Related]
35. Comparison of allergen-induced changes in bronchial hyperresponsiveness and airway inflammation between mildly allergic asthma patients and allergic rhinitis patients.
Alvarez MJ; Olaguibel JM; Garcia BE; Tabar AI; Urbiola E
Allergy; 2000 Jun; 55(6):531-9. PubMed ID: 10858983
[TBL] [Abstract][Full Text] [Related]
36. Fevipiprant, a prostaglandin D2 receptor 2 antagonist, in patients with persistent eosinophilic asthma: a single-centre, randomised, double-blind, parallel-group, placebo-controlled trial.
Gonem S; Berair R; Singapuri A; Hartley R; Laurencin MFM; Bacher G; Holzhauer B; Bourne M; Mistry V; Pavord ID; Mansur AH; Wardlaw AJ; Siddiqui SH; Kay RA; Brightling CE
Lancet Respir Med; 2016 Sep; 4(9):699-707. PubMed ID: 27503237
[TBL] [Abstract][Full Text] [Related]
37. Vitamin D reduces eosinophilic airway inflammation in nonatopic asthma.
de Groot JC; van Roon EN; Storm H; Veeger NJ; Zwinderman AH; Hiemstra PS; Bel EH; ten Brinke A
J Allergy Clin Immunol; 2015 Mar; 135(3):670-5.e3. PubMed ID: 25617224
[TBL] [Abstract][Full Text] [Related]
38. Sputum in severe exacerbations of asthma: kinetics of inflammatory indices after prednisone treatment.
Pizzichini MM; Pizzichini E; Clelland L; Efthimiadis A; Mahony J; Dolovich J; Hargreave FE
Am J Respir Crit Care Med; 1997 May; 155(5):1501-8. PubMed ID: 9154849
[TBL] [Abstract][Full Text] [Related]
39. Effect of a single dose of salmeterol on the increase in airway eosinophils induced by allergen challenge in asthmatic subjects.
Dente FL; Bancalari L; Bacci E; Bartoli ML; Carnevali S; Cianchetti S; Di Franco A; Giannini D; Vagaggini B; Testi R; Paggiaro PL
Thorax; 1999 Jul; 54(7):622-4. PubMed ID: 10377209
[TBL] [Abstract][Full Text] [Related]
40. Attenuation of aspirin-induced bronchoconstriction by sodium cromoglycate and nedocromil sodium.
Robuschi M; Gambaro G; Sestini P; Pieroni MG; Refini RM; Vaghi A; Bianco S
Am J Respir Crit Care Med; 1997 Apr; 155(4):1461-4. PubMed ID: 9105094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
